Which COVID-19 patients should be recommended for home isolation and which should be hospitalized? Predictors of disease progression for mild COVID-19 patients
A multivariate regression model was created according to the results of univariate analyses.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Background/aim: Each country has different treatment and home isolation recommendations regarding the management of mild COVID-19 patients, and there is not yet a standard approach.
📊
Key Findings & Data:The aim of this study is to determine which patients are suitable for home isolation by identifying the variables that predict the progression of the disease in mild COVID-19 patients.
💡
Conclusion & Impact:A multivariate regression model was created according to the results of univariate analyses.
Background/aim: Each country has different treatment and home isolation recommendations regarding the management of mild COVID-19 patients, and there is not yet a standard approach. The aim of this study is to determine which patients are suitable for home isolation by identifying the variables that predict the progression of the disease in mild COVID-19 patients. Materials and methods: This prospective observational study included laboratory confirmed mild COVID-19 patients older than 18 years. The primary outcome of the study was the disease progression in mild COVID-19 patients. A multivariate regression model was created according to the results of univariate analyses. Results: A total of 254 patients included in the study. Median age of the patients was 34.5 years (27–42), and 132 (52%) of them were male. COVID-19 compatible thoracic computed tomography appearance (P
AKSEL, G., ADEMOĞLU, E., İSLAM, M. M., YAŞAR, G. B., TENGEREK, D., DÖLEK, M. Ü. C., DAŞDELEN, S., EROĞLU, S. E. (2021). Which COVID-19 patients should be recommended for home isolation and which should be hospitalized? Predictors of disease progression for mild COVID-19 patients. Journal of Experimental and Clinical Medicine, Cilt: 38 - Sayı: 4, 490–495. https://ajindex.com/articles/677840
Khan G, Sheek-Hussein M, Al Suwaidi AR, Idris K, Abu-Zidan FM. Novel coronavirus pandemic: A global health threat. Turkish Jounal of Emergency Medicine. 2020 May 27;20(2):55-62. doi: 10.4103/2452-2473.285016
Bartsch SM, Ferguson MC, McKinnell JA, O'Shea KJ, Wedlock PT et al. The Potential Health Care Costs And Resource Use Associated With COVID-19 In The United States: A simulation estimate of the direct medical costs and health care resource use associated with COVID-19 infections in the United States. Health Affairs (Millwood). 2020 Jun;39(6):927-935. doi: 10.1377/hlthaff.2020.00426
Li X, Wang Y, Agostinis P, Rabson A, Melino G et al. Is hydroxychloroquine beneficial for COVID-19 patients? Cell Death & Disease. 2020 Jul 8;11(7):512. doi: 10.1038/s41419-020-2721-8
Boulware DR, Pullen MF, Bangdiwala AS, Pastick KA, Lofgren SM et al. A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19. New England Jounal of Medicine. 2020 Aug 6;383(6):517-525. doi: 10.1056/NEJMoa2016638